API

Event: 1514

Key Event Title

?

Neurodegeneration

Short name

?

Neurodegeneration

Biological Context

?

Level of Biological Organization
Organ


Organ term

?


Key Event Components

?

Process Object Action

Key Event Overview


AOPs Including This Key Event

?


Stressors

?


Taxonomic Applicability

?


Life Stages

?


Sex Applicability

?


Key Event Description

?


Neurodegeneration is the loss of neuron cells in the brain and spinal cord. The loss of neurons can either be functional loss, also called ataxia, or sensory dysfunction, known as dementia. The brain is organized in different parts which all have their own function in an individual. So which affect the neurodegeneration has on an individual it depends on where neuron loss occurs.


How It Is Measured or Detected

?


A biomarker is needed since a common way to detect neurodegeneration is with the use of a PET scan. Although this technique works, another in vitro method needed to predict whether a chemical can induce neurodegeneration before it damages a whole brain. A possible biomarker of neurodegeneration can be found in the cerebrospinal fluid. These biomarkers are the spectrin breakdown products, specifically SBDP-145. There are two possible ways of measuring SBDP-145. First quantification can be done with an ELISA technique, from a sample taken out of the cerebrospinal fluid. Another way is to label SBDP-145 with the use of immunohistochemistry, so that the expression and release of SBDP-145 can be made visible.


Domain of Applicability

?



Regulatory Significance of the Adverse Outcome

?



References

?


Uttara, B., Singh, A. V, Zamboni, P. & Mahajan, R. T. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr. Neuropharmacol. 7, 65–74 (2009).

Pritt, M. L. et al. Initial biological qualification of SBDP-145 as a biomarker of compound-induced neurodegeneration in the rat. Toxicol. Sci. 141, 398–408 (2014).